HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia Rejects Hair-Loss Switch, Up-Schedules Modified-Release Paracetamol

Executive Summary

Australia has rejected an application to switch an oral hair-loss treatment, while also up-scheduling modified release paracetamol over safety concerns.

You may also be interested in...



Ibuprofen Better Than Paracetamol At Reducing Fever In Children And Just As Safe – Study

A meta-analysis finds moderate-quality evidence that compared with paracetamol (also known as acetaminophen), ibuprofen is more effective at reducing fever in children under two years old, and despite concerns, has a similar safety profile.

France's ANSM Moves Paracetamol, Ibuprofen And Aspirin Behind The Counter

France restricts sales of medicines containing paracetamol, ibuprofen and aspirin to behind the pharmacy counter due to safety concerns.

France Wants To Move Paracetamol, Ibuprofen And Aspirin Behind The Counter

France's medicines agency wants to restrict sales of OTC drugs containing paracetamol, ibuprofen and aspirin to behind the pharmacy counter due to safety concerns.

Related Content

Topics

UsernamePublicRestriction

Register

RS149248

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel